MedPath

COVID-19 Related Health and Infection Control Practices Among Dentists

Completed
Conditions
Severe Acute Respiratory Syndrome Coronavirus 2
Interventions
Other: No intervention
Registration Number
NCT04423770
Lead Sponsor
American Dental Association
Brief Summary

As dentists begin reopening their practices during a global pandemic, the risk of COVID-19 infection that dentists face in providing dental care remains unknown. Estimating the occupational risk of COVID-19, and producing evidence on the types of infection control practices and dental practices that may affect COVID-19 risk, is therefore imperative. The goal of the proposed study is to understand U.S.-based dentists' health and dental-practice reactions to COVID-19. To estimate this, U.S-based dentists will be surveyed monthly. These findings could be used to describe the prevalence and incidence of COVID-19 among dentists, determine what infection control steps dentists take over time, and estimate whether infection control adherence in dental practice is related to COVID-19 incidence.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2196
Inclusion Criteria
  • Primary dental practice is in United States
  • 18 years of age or older
  • Dentist
Exclusion Criteria

•Answered "no" to ADA survey sent May 2020 that read "As part of ongoing efforts to monitor the effect of COVID-19 on the dental team, the ADA is interested in collecting data related to infection rates. Would you also be willing to participate in a separate, longitudinal study that would require you to report whether you or your staff have exhibited symptoms of COVID-19, and whether you have been tested or diagnosed? The study would be anonymous and under IRB protocols."

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
U.S. dentistsNo interventionDentists in the United States
Primary Outcome Measures
NameTimeMethod
COVID-19 probable or confirmed case18 months

COVID-19 case as confirmed by clinician and/or detection of SARS-CoV-2 RNA or a specific antigen in a clinical specimen

Secondary Outcome Measures
NameTimeMethod
Anxiety12 months

Assessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4). Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater anxiety.

Depression12 months

Assessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4). Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater depressive symptoms.

Dental practice infection control efforts12 months

Self-reports of infection control efforts in the respondents' primary dental practices

Dentists' use of personal protective equipment12 months

Self-reports of personal protective equipment use

Trial Locations

Locations (1)

American Dental Association

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath